(Q35964751)

11 August 2017

1 reference

title

Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection (English)

1 reference

11 August 2017

0 references

0 references

cytomegaloviral disease

1 reference

Wivine Burny

1

1 reference

11 August 2017

Corinne Liesnard

series ordinal

2

1 reference

11 August 2017

Catherine Donner

series ordinal

3

1 reference

11 August 2017

Arnaud Marchant

series ordinal

4

1 reference

11 August 2017

1 December 2004

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

1 reference

11 August 2017

2

1 reference

11 August 2017

881-894

1 reference

11 August 2017

6

1 reference

Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection

11 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Congenital Cytomegalovirus Disease — 20 Years Is Long Enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Cytomegalovirus transmission from breast milk in premature babies: does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Maternal immunity and prevention of congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Variable outcome of a congenital cytomegalovirus infection in a quadruplet after primary infection of the mother during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Polarized release of human cytomegalovirus from placental trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

The human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Human Cytomegalovirus Inhibits Differentiation of Monocytes into Dendritic Cells with the Consequence of Depressed Immunological Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Prenatal diagnosis of congenital cytomegalovirus infection by virus isolation from amniotic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Antiviral drugs in current clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Clinical aspects and management of cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

New developments in the diagnosis of maternal and congenital CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Congenital cytomegalovirus infection treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Congenital cytomegalovirus (CMV) infections: hats off to Alabama

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

CMV-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

The cellular immunotherapy of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Encouraging prospects for immunisation against primary cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

DNA vaccines against cytomegalovirus: current progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Severe herpesvirus infections in an adolescent without natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Ganciclovir Treatment of Congenital Cytomegalovirus Infection: A report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

Human Cytomegalovirus (HCMV) Replication Dynamics in HCMV‐Naive and ‐Experienced Immunocompromised Hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789072.2.6.881

21 January 2018

Identifiers

DOI

10.1586/14789072.2.6.881

1 reference

11 August 2017

1 reference